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acid) resulted more active as a chondroprotector. The GR 375 
and GR 377, which are respectively the N,N-diethyl and diphene- 
tidin 2,6 disulfonamide derivatives of GR 373, are more active on 
bone. In this research we investigate the effect of GR 375 and GR 
377 on trabecular and subchondral bone in experimental animal. 
Methods: 18 female Wistar rats having a body weigth of 1804-10 
g were subjected to an experimentally-induced osteoporosis by 
surgically removing the ovaries. The animals were divided into 
three groups as follows: 1) control, 2) treated with GR 375 25 
mg/kg/os and 3) treated with GR 377 at the same dosage. Af- 
ter a three-month treatment period the rats were sacrificed and 
their posterior legs removed and stored in formalin solution at pH 
7.2. They were then dehydrated with warm methyl alcohol under 
vacuum and methyl methacrylate mbedded. Frontal 100 and 20- 
30 i~m thick sections of the specimens were prepared to evalu- 
ate the effect of treatment. Microradiographs of the femoral head 
and neck region were taken. The trabecular bone volume (%TBV) 
was measured histologically. The results indicate the treated an- 
imals (GR 377:54.53 4- 7.37, GR 375:49.48 4- 9.97) to have 
a greater %TBV when compared to the control group (41.32 4- 
4.54), nonetheless statistical significance was obtained only for 
the GR 377 treated group. Similar results were obtained after 
having assessed the tibial trabecular thickness. The subchondral 
and cortical components of bone were also markedly increased 
in the treated animals when compared to their control counter- 
parts.Bone density and mineralization are statistically higher in 
treated animals. 
Conclusion: 2,6 diphenetidine anthraquinone disulphonamide 
(GR 377) has been shown to be effective in increasing bone 
mass in the trabecular, subchondral and cortical components of 
bone in the ovariectomized rat. N,N' diethyl 2,6 anthraquinone 
disulphonamide (GR 375) was also shown to be effective, al- 
though not to the same extent as that of GR 377. Other studies 
have demonstrated these compounds to significantly decrease 
IL-6 and iNOS in LPS-challenged rats and to modulate the ex- 
pression of some proteins in bone metabolism and mineraliza- 
tion. The data suggest that one mechanism of GR 377 and GR 
375 action is the modulation of bone gene expression. 
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In previous studies, we had shown increased BMD in the long 
bones of an inlammatory arthritis model in the rat, by feeding 
GIcNBu (N-butyryl glucosamine). The aim of this study is to deter- 
mine if oral admininistration of GIcNBu affects BMD, bone growth 
and gene expression in the non-OVX and the OVX-rat model. 
Female Sprague Dawley rats were randomized into four Groups 
(8 animals each). In addition to their normal diet, the animals 
were fed on a daily basis (once a day), with either of GIcNBu 200 
mg/kg, or an equimolar amount of glucose (GIc) for 6 months. 
Groups 1,2, 3 and 4 were, respectively: GIc-fed, non-OVX, (Con- 
trol); GIcNBu-fed, non-OVX; GIc-fed, OVX; GIcNBu-fed, OVX. 
The BMD and body composition was measured by DXA (Ho- 
logic 4500, small animal software) every 2 months. At sacrifice (6 
months), femurs were removed for physical measurements. The 
total RNA from the liver was extracted (RNeasy Kit, Qiagen) and 
gene expression was assessed by microarray (rat 8K gene, flu- 
orescent Cy3 and Cy5), with Group 1 serving as the control for 
each of Groups 2-4. 
The results showed that there was increased length of femurs 
for Group 4 vs 3 and in femoral wet weights (trends), as well as 
for Group 2 vs 1 (Fig. 1). As expected, OVX led to increased 
body mass. The BMD of Group 4 femoral heads were higher than 
Group 3. Total body mineral content + lean body mass was also 
highest in Group 4. 
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Fig. 1. Effect of GIcNBu on femoral length (OVX and Controls). 
By microarray (all compared to Group 1), the number of regu- 
lated genes (> 2-fold) in the liver were: Group 2, 13; Group 3, 40; 
Group 4, 57. A small number of genes were highly regulated only 
in Group 3. 
We conclude that oral administration of GIcNBu results in en- 
hanced growth and increased BMD of femurs in the OVX rat. The 
microarray analysis (rat 8K gene chip) showed that a number of 
genes in the liver were remarkably regulated by GIcNBu. Compar- 
isons of the 4 experimental Groups suggest that GIcNBu feeding 
selectively regulates some genes post-ovariectomy. Since some 
of the selectively up-regulated genes in Group 4 encode for ciru- 
lating protein growth factors, we speculate that this may constitute 
a mechanism of action for the effects of GIcNBu on bone. 
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Aim of Study: Tissues such as cartilage and the intervertebral 
disc (IVD) are hypoxic and avascular and this affects glycolysis 
and cell metabolism. We have recently shown that human chon- 
drocytes express the hypoxia-inducible transcription factor alpha 
(H IF-1 ~), along with a number of facilitative glucose transporters 
including GLUT1, GLUT3 and GLUT9. Other groups have shown 
that cells from the rat nucleus pulposus (NP) express both GLUT1 
and H IF-1 ~, yet to date, no studies have identified the expression 
of HIF-I~ or other GLUTs in the human intervertebral disc. In this 
study we have used immunohistochemistry (IHC) to examine the 
expression of HIF-I~, GLUT1, GLUT3 and GLUT9 in normal and 
degenerate IVDs. 
Methods: Thirty-one paraffin-embedded human intervertebral 
disc biopsies were chosen for analysis. These included 10 non- 
degenerate and 21 degenerate discs. IHC was conducted using 
antibodies against HIF-I~, GLUT1, GLUT3 and GLUT9 and hu- 
man tissue microarrays erved as positive controls. 
Results: IHC confirmed that HIF-I~ and GLUTs 1, 3 and 9 pro- 
teins were all expressed in the normal human IVD. Expression 
